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Cdk5-Mediated Inhibition of the Protective
Effects of Transcription Factor MEF2
in Neurotoxicity-Induced Apoptosis
prehensive molecular mechanisms that couple toxic in-
sults to apoptosis remain to be elucidated.
Cyclin-dependent kinase 5 (Cdk5) is a proline-directed
serine/threonine kinase whose activity is highest in post-
mitotic neurons. In contrast to classic Cdks whose activ-
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diseases primarily through a cytoplasmic mechanismsubstrates. However, its roles in the nucleus remain
(Grant et al., 2001; Maccioni et al., 2001). Consistentunknown. Here we investigate the mechanism by
with this hypothesis, both Cdk5 and p35 are enrichedwhich Cdk5 promotes neuronal apoptosis. We have
in the cytoplasm of neurons where Cdk5 phosphorylatesidentified the prosurvival transcription factor MEF2 as
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reveal a nuclear pathway by which neurotoxin/Cdk5 Nevertheless, the biological significance of Cdk5 in the
induces neuronal apoptosis through inhibiting prosur- nucleus remains unknown.
vival nuclear machinery. Myocyte enhancer factor 2 (MEF2, isoforms A-D) fam-
ily of transcription factors plays critical roles in diverse
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be due to crosscontamination of nuclear preparations
by cytoplasmic fractions, as the same nuclear prepara-
tion was negative for cytoplasmic marker c-Raf-1. Simi-
larly, crosscontamination of cytoplasmic preparation by
nuclear fraction was also minimal. We corroborated
Western blotting findings by immunocytochemical anal-
ysis using isolated nuclei from cortical neurons (Nuclei
EZ prep, Sigma) (see Supplemental Figure S1 at http://
www.neuron.org/cgi/content/full/38/1/33/DC1). These re-
sults confirm the nuclear coexpression of Cdk5 and p35
with MEF2 in cultured cortical neurons, suggesting that
Cdk5/p35 kinase complex is in a position to regulate
MEF2.
Phosphorylation of MEF2 by Cdk5
Figure 1. Coexpression of Endogenous Cdk5, p35, and MEF2D in In Vitro and In Vivo
the Nucleus of Cultured Primary Cortical Neurons Examining the protein sequence of MEF2s revealed the
Lysates of primary cortical neurons were fractionated into cyto- presence of a putative Cdk5-phosphorylation site con-
plasmic or nuclear fractions (indicated by C and N, respectively). The
served among all members of MEF2 family within theirsubcellular distribution of Cdk5, p35, MEF2D, c-Raf-1 (cytoplasmic
more divergent carboxyl transactivation domain (Figuremarker), and Histone H1 (nuclear marker) was determined by West-
2A), suggesting that MEF2 may be phosphorylated di-ern blotting using the indicated antibodies.
rectly by Cdk5. We sought to determine whether MEF2
is a direct substrate of Cdk5 using an in vitro kinase
assay. The recombinant carboxy-terminal fragments ofWe report here that MEF2 is a Cdk5 substrate both
MEF2A, C, and D (referred to as C’-MEF2 hereafter)in vitro and in vivo. Phosphorylation of MEF2 by Cdk5
encompassing much of the transactivation domain wereresults in inhibition of MEF2 transactivation activity.
phosphorylated by purified Cdk5/p25 to about the sameNeurotoxicity increases nuclear Cdk5 kinase activity,
level (Figure 2B) (purified Cdk5/p35 complex also phos-leading to a Cdk5-dependent phosphorylation and inhi-
phorylated MEF2 efficiently; see Supplemental Figurebition of MEF2 function. Moreover, MEF2 mutants that
S2 at http://www.neuron.org/cgi/content/full/38/1/are resistant to Cdk5 phosphorylation rescue neurons
33/DC1). The amino terminus of MEF2, on the otherfrom neurotoxin/Cdk5-induced apoptosis. Our results
hand, was not phosphorylated to any appreciable level,show that inactivation of MEF2 by Cdk5-dependent
indicating that Cdk5 selectively recognizes the carboxylphosphorylation represents part of the molecular mech-
portion of the MEF2 molecule (data not shown). Phos-anism by which neurotoxin/Cdk5 mediates apoptosis,
phoamino-acid analysis of the C’-MEF2D phosphory-thus establishing a nuclear pathway that may underlie
lated in vitro indicated that Cdk5 can phosphorylatethe process of neurodegeneration.
serine residue of C’-MEF2D (Figure 2C). Further studies
were performed using phosphopeptide mapping toResults
identify the sequences phosphorylated. Two phospho-
peptides of C’-MEF2D were detected (Figure 2D). Pep-Coexpression of Cdk5, p35, and MEF2 in the
tide I was phosphorylated at much higher level thanNucleus of Primary Cortical Neurons
peptide II, suggesting that Cdk5 mainly recognizes theBased on the findings that deregulation of Cdk5 activity
serine residue(s) in peptide I. Given that Cdk5 preferen-induces neuronal apoptosis whereas MEF2 promotes
tially recognizes serine/threonine residues in the contextneuronal survival (Kusakawa et al., 2000; Mao et al.,
of S/TPXK/R (Sharma et al., 1999), Ser444 of MEF2D within1999; Patrick et al., 1999), we hypothesized that nuclear
the consensus S444PSR seemed the likely Cdk5 target.Cdk5 may target prosurvival transcription factors such
To investigate whether Ser444 is indeed phosphorylatedas MEF2. To investigate the potential involvement of
by Cdk5, we mutated Ser444 to Ala (MEF2DS444A) andCdk5 in regulating MEF2, we first sought to demonstrate
tested the effect of this mutation on phosphorylation bynuclear codistribution of Cdk5, p35, and MEF2 in our
Cdk5. Mutation at Ser444 led to a significant reductionmodel of cultured primary cortical neurons. Previous
of Cdk5 phosphorylation of C’-MEF2D (Figure 2E) andstudies have shown expression of MEF2 isoforms in the
a loss of the inducible phosphorylation of peptide I (datanucleus of cortical neurons. Using specific antibodies
not shown), establishing Ser444 of MEF2D as the majoragainst Cdk5, p35, and MEF2D (no crossreactivity; data
site phosphorylated by Cdk5.not shown), we determined by Western blotting the ex-
To examine Cdk5-mediated phosphorylation of MEF2pression levels of these proteins in the nuclear extracts
in cells, we metabolically labeled HEK293 cells that wereprepared from cultured primary cortical neurons. High
transiently transfected with a construct for GAL4-levels of Cdk5 and p35 were present in the cytoplasmic
MEF2A with 32P-orthophosphate and determined theextracts, consistent with previous findings. Although
levels of phosphorylation by autoradiography followingless abundant than in the cytoplasm, both Cdk5 and
anti-GAL4 immunoprecipitation. Compared to the con-p35 were consistently detected by Western blotting in
trol, the level of GAL4-MEF2A phosphorylation wasthe nuclear fractions from cortical neurons, codistribut-
greatly enhanced with the coexpression of Cdk5/p25ing with nuclear marker Histone H1 and MEF2D (Figure
1). The nuclear signals of Cdk5 and p35 are unlikely to (Figure 2F, top panel). Mutation of Ser408 of GAL4-MEF2A
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Figure 2. MEF2 Is a Substrate of Cdk5
(A) Regional sequence alignment of members of the MEF2 family. The numbers indicate the starting and ending positions of amino acid
residues of each MEF2 isoform shown. Bold letters mark the sequence that matches the Cdk5 consensus site with the phosphorylatable
serine numbered and underlined.
(B) Cdk5 phosphorylates members of MEF2 family in vitro. Purified recombinant C-terminal fragments of MEF2A, C, and D (C’-MEF2) were
phosphorylated by purified Cdk5/p25 in vitro in the presence of [-32P]ATP. Results of autoradiography following SDS-PAGE are shown.
(C) Phosphoamino acid analysis of C’-MEF2D phosphorylated by Cdk5/p25 in vitro. C’-MEF2D phosphorylated in vitro by Cdk5/p25 was
subjected to phosphoamino acid analysis as described (Boyle et al., 1991). Circles indicate the positions of phospho Tyr and Thr.
(D) Phosphopeptide mapping of C’-MEF2D phosphorylated by Cdk5/p25 in vitro. C’-MEF2D phosphorylated in vitro by Cdk5/p25 was subjected
to phosphopeptide analysis as described (Boyle et al., 1991).
(E) The effect of Ser444 to Ala mutation (S444A) on the phosphorylation of C’-MEF2D by Cdk5 in vitro. Wild-type C’-MEF2D and mutant C’-
MEF2DS444A were phosphorylated in vitro as described above (top panel). Quantification of the recombinant proteins used for the kinase
assay is shown as Coomassie blue staining (bottom panel).
(F) In vivo phosphorylation and phosphopeptide analysis of GAL4-MEF2A by Cdk5/p25. HEK293 cells were transfected with indicated constructs
and then metabolically labeled with 32P orthophosphate for 3 hr. GAL4-MEF2A was immunoprecipitated from transfected HEK293 cells and
autoradiography is shown (top panel). In vivo phosphorylated GAL4-MEF2A from top panel was subjected to peptide mapping. Cdk5-induced
phosphorylation of peptide I of GAL4-MEF2A had Rf and mr values similar to that of the control peptide of C’-MEF2A phosphorylated by Cdk5
in vitro (second from left and far right panels, respectively). Inducible phosphorylation of peptide I was absent if Ser408 was mutated (indicated
by circle in second panel from right).
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within the consensus Cdk5 site S408PPR, equivalent of MEF2 reporter assay in neurons. For these studies, we
used wild-type and Ser408 to Ala mutant of GAL4-MEF2A.Ser444 of MEF2D, to Ala (GAL4-MEF2AS408A) signifi-
cantly reduced the level of Cdk5-induced GAL4-MEF2A Transfection of primary cortical neurons with constructs
expressing GAL4-MEF2A and GAL4-luciferease reporterphosphorylation. These findings are confirmed by phos-
phopeptide mapping experiments, demonstrating that resulted in increased luciferase activity. Coexpression
of Cdk5/p25 inhibited GAL4-MEF2A activity, and thisCdk5-induced phosphorylation of peptide I was blocked
if Ser408 was mutated to Ala (Figure 2F, bottom panel). inhibition was blocked by Roscovitine (Figure 3D), sug-
gesting that the fusion protein GAL4-MEF2A is regulatedThese results indicate that Cdk5 induces GAL4-MEF2A
phosphorylation specifically at Ser408 in cells. similarly by Cdk5 as MEF2 proteins. The suppression
of GAL4-MEF2A by Cdk5 depended on Ser408 since a
Ser408 to Ala mutant GAL4-MEF2AS408A, which is ex-
pressed at a level comparable to that of wild-type GAL4-Inhibition of MEF2 Transactivation Activity
by Cdk5-Mediated Phosphorylation MEF2A (Figure 3E, bottom panel), was resistant to Cdk5/
p25-mediated inhibition (Figure 3E), demonstrating thatTo investigate how phosphorylation by Cdk5 regulates
the transactivation activity of MEF2, we employed a the inhibitory effects of Cdk5 on GAL4-MEF2A specifi-
cally involve Ser408. These findings are consistent withMEF2 activity-dependent reporter gene system in which
the expression of the reporter gene luciferase is con- our phosphorylation studies (Figure 2) and suggest that
Ser408a/444d (Ser408 of MEF2A and Ser444 of MEF2D) is thetrolled by two MEF2 DNA binding elements (MEF2-luc).
Cultured primary cortical neurons, which express high critical phosphorylation site that mediates the inhibitory
effect of Cdk5 on MEF2 in neurons.levels of endogenous MEF2s, Cdk5, and its regulator
p35 (Leifer et al., 1993; Mao et al., 1999; McDermott et
al., 1993; Nikolic et al., 1996), were transfected with the Oxidative Stress-Induced Elevation of Nuclear Cdk5
MEF2 luciferase reporter plasmid along with constructs Kinase Activity and MEF2 Phosphorylation
for Cdk5 and/or p25. A plasmid that directs the expres- Neurotoxicity deregulates Cdk5 activity in vivo, which
sion of-galactosidase (-gal) was included in the trans- may contribute to the pathogenesis of Alzheimer’s dis-
fection assays as an internal control for transfection ease and ALS (Nguyen et al., 2001; Patrick et al., 1999;
efficiency. Introduction of either Cdk5 or p25 into corti- Yuan and Yankner, 2000). Oxidative stress plays a cen-
cal neurons greatly reduced the MEF2-dependent lucif- tral role in mediating the toxic effects of many neurotox-
erase activity (Figure 3A). Coexpression of Cdk5 and ins including amyloid (Butterfield et al., 2001). To inves-
p25 resulted in even greater inhibition, suggesting that tigate whether neurotoxicity may induce cell death
enhanced Cdk5 activity inhibits the function of endoge- through Cdk5-mediated inhibition of MEF2, we studied
nous MEF2. Similar results were obtained with p35 alone the effect of oxidative stress on nuclear Cdk5 activity
or in combination with Cdk5 (see Supplemental Figure by treating cortical neurons with hydrogen peroxide.
S3 at http://www.neuron.org/cgi/content/full/38/1/ Using a Cdk5 immunoprecipitation/in vitro kinase assay
33/DC1). This reduction of MEF2 function was mainly approach, we consistently found the presence of a low
due to the inhibition of MEF2 transactivation activity, as level of Cdk5 activity in the control nucleus and cyto-
the level of MEF2 protein was not affected significantly plasm (Figure 4A, left lane). Hydrogen peroxide treat-
under our experimental conditions (data not shown). ment did not significantly affect the levels of nuclear
Furthermore, inhibition of MEF2 function by Cdk5 was Cdk5 protein (nor did it affect p35 level; data not shown)
not the result of general transcription suppression be- but markedly increased nuclear and cytoplasmic Cdk5
cause expression of the luciferase reporter gene under kinase activity (Figure 4A, middle lane) (densitometry
the control of neuropathy target esterase (NTE) pro- analysis adjusted for Cdk5 level: 82% and 76% increase,
moter was not inhibited by overexpression of Cdk5/p25 respectively; Figure 4A, bottom panel). Roscovitine sig-
(Figure 3B). To confirm that the observed inhibition of nificantly reduced the increase in nuclear and cyto-
MEF2 transactivation activity depends on Cdk5 kinase plasmic Cdk5 activity (Figure 4A, right lane) (118% and
activity, we tested the effects of a dominant-negative 55% reduction, respectively). These results suggest that
form of Cdk5 (dnCdk5) on MEF2 reporter gene expres- increased Cdk5 activity may mediate the effects of neu-
sion. dnCdk5 contains a point mutation in its Mg2 che- rotoxin in the nucleus.
lating site that abolishes its kinase activity but enhances To determine whether neurotoxicity induces Cdk5-
its interaction with regulators. Consequently, it inhibits mediated MEF2 phosphorylation, we carried out phos-
the function of endogenous Cdk5 by sequestering p35 or phopeptide mapping analysis to examine the phosphor-
p25 (Nikolic et al., 1996). Introduction of dnCdk5 largely ylation of endogenous MEF2D in cortical neurons upon
reversed the inhibitory effects of Cdk5 and p25 on MEF2 neurotoxic insult. Following hydrogen peroxide treat-
reporter expression (Figure 3A). Similarly, Roscovitine, ment, endogenous MEF2D was immunoprecipitated
a selective Cdk5 inhibitor, effectively blocked Cdk5/p25- from metabolically labeled primary neurons and its level
dependent inhibition of MEF2 reporter gene (Figure 3C). of phosphorylation was determined by mapping. Hydro-
These studies indicate that elevated Cdk5 kinase activity gen peroxide significantly enhanced the phosphoryla-
is capable of inhibiting MEF2-dependent gene expres- tion of a peptide (4.3-fold increase versus control) that
sion in vivo and further suggest that phosphorylation of comigrated with a Ser444-containing control peptide of
MEF2 by Cdk5 downregulates MEF2 activity. MEF2D phosphorylated by Cdk5 in vitro (Figure 4B, indi-
To address the role of Ser444 in Cdk5/p25-mediated cated by arrow, second and fourth panels from left). The
regulation of MEF2, we studied the effects of Ser444 mu- inducible phosphorylation of this peptide was largely
blocked by Cdk5 inhibitor, Roscovitine (90% inhibitiontation on Cdk5-induced inhibition of MEF2 using GAL4-
Inhibition of MEF2 by Cdk5
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Figure 3. Cdk5/p25 Inhibits the Transactivation Activity of MEF2
(A) Coexpression of Cdk5 and p25 inhibits MEF2-dependent luciferase reporter activity in primary cortical neurons. Primary cortical neurons
were transiently transfected with the indicated constructs as described under Experimental Procedures (mt, luciferase reporter with MEF2
binding sites mutated; wt, luciferase reporter with wild-type MEF2 binding sites). Luciferase and -gal activities were determined 20 hr after
transfection, and relative fold of luciferase activity was determined after adjusting for -gal level (mean  SEM, n  3).
(B) Coexpression of Cdk5/p25 does not inhibit luciferase reporter activity under the control of NTE promoter. NTE luciferase reporter assays
were carried out in the same series of experiment as in (A) (mean  SEM, n  3).
(C) Pharmacological inhibitor of Cdk5 Roscovitine reduces Cdk5-mediated inhibition of MEF2 function. Primary cortical neurons were trans-
fected for 12 hr and then treated with either vehicle (DMSO, in black), or 10 M Roscovitine (gray). Luciferase activity was measured 1 hr
after treatment (mean  SEM, n  3).
(D) Cdk5/p25 inhibits the function of GAL4-MEF2A. Cortical neurons were transfected with GAL4 luciferase reporter and other indicated
constructs and treated as described in (C) (mean  SEM, n  3).
(E) The inhibitory effect of Cdk5/p25 on MEF2A involves Ser408. Cortical neurons were transfected with indicated constructs and treated as
described in (A) (mean  SEM, n  3). The bottom panel is anti-GAL4 Western blotting analysis of GAL4-MEF2A (wild-type or S408A mutant)
expression following transfection.
adjusted for background) (Figure 4B, third panel from increase in MEF2D phosphorylation at Ser444 recognized
by the phospho antibody (Figure 4D, middle panel) (den-left). Together with data presented in Figure 2, these
studies suggest that oxidative stress induces the phos- sitometry analysis adjusted for loading: H2O2, 2.7-fold
increase versus control; Roscovitine, over 50% reduc-phorylation of endogenous MEF2D at Ser444 through a
mechanism mediated by Cdk5. tion versus H2O2 treatment), suggesting that neurotoxic-
ity induces phosphorylation of MEF2 at Ser444 in neurons.To corroborate the results of neurotoxin-induced
phosphorylation of endogenous MEF2 in neurons, we The effective inhibition of MEF2 phosphorylation at
Ser444 by Roscovitine largely excludes p38MAPK, ERK5,generated an antibody that recognizes MEF2A and D
phosphorylated at Ser408a/444d (Figure 4C). We metaboli- GSK3, or Cdk4/6 as the candidate kinases that phos-
phorylate Ser444 in vivo because their activities are notcally labeled hydrogen peroxide-treated primary cortical
neurons with 32P-orthophosphate and immunoprecipi- sensitive to Roscovitine.
To demonstrate that Cdk5 directly mediates neuro-tated MEF2D. Hydrogen peroxide treatment enhanced
32P-labeling of MEF2D, which was inhibited by Roscovi- toxin-induced phosphorylation and inhibition of MEF2,
we tested the effect of the specific Cdk5 inhibitor,tine (Figure 4D, top panel) (similar results were obtained
for MEF2C; see Supplemental Figure S4 at http:// dnCdk5, on neurotoxicity-dependent phosphorylation
of MEF2. Cortical neurons transfected with a constructwww.neuron.org/cgi/content/full/38/1/33/DC1). When the
same membrane was probed with phospho-MEF2 anti- for GAL4-MEF2D were treated with hydrogen peroxide,
and the phosphorylation level of GAL4-MEF2D at Ser444body, this enhanced 32P labeling corresponded to an
Neuron
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Figure 4. Oxidative Stress Elevates Nuclear Cdk5 Kinase Activity and Induces MEF2 Phosphorylation at Ser444
(A) Top panel: hydrogen peroxide enhances nuclear and cytoplasmic Cdk5 kinase activity. In vitro Cdk5 kinase assay was performed following
immunoprecipitation of Cdk5 from cytoplasmic or nuclear extracts of control (left lane), hydrogen peroxide (90 M for 4 hr, middle lane), and
hydrogen peroxide/Roscovitine (10 M, right lane) -treated cortical neurons. The level of Cdk5 kinase activity was determined as described
in Figure 2B. The level of Cdk5 protein was determined by Western blot. Bottom panel indicates average of adjusted Cdk5 kinase activity
(mean  SD, n  3).
(B) Analysis of H2O2-induced phosphorylation of endogenous MEF2D by in vivo labeling and phosphopeptide mapping. Cortical neurons were
metabolically labeled with 32P orthophosphate for 4 hr and then treated with or without hydrogen peroxide (90 M) and Roscovitine (10 M)
for 4 hr. Endogenous MEF2D was immunoprecipitated from cells following treatment and subjected to phosphopeptide analysis. H2O2 treatment
induced phosphorylation of a peptide of MEF2D with Rf and mr values similar to that of the control Ser444-containing peptide of C’-MEF2D
phosphorylated by Cdk5 in vitro (indicated by arrow, second from left and far right panels, respectively). Inducible phosphorylation of this
peptide was reduced by Roscovitine (second panel from right).
(C) Characterization of an antibody that recognizes MEF2D phosphorylated at Ser444. Bacterially expressed C’-MEF2D or its mutant S444A
were phosphorylated by Cdk5 in vitro with cold ATP. Western blot analysis was performed using either preimmune or postimmune sera from
a rabbit immunized with a peptide containing a phosphorylated serine residue corresponding to position 444. p or p indicates MEFD
proteins either phosphorylated or unphosphorylated by Cdk5, respectively.
(D) H2O2 induces phosphorylation of MEF2D at Ser444 in primary cortical neurons. MEF2D from cortical neurons metabolically labeled with 32P
orthophosphate was immunoprecipitated with an anti-MEF2D antibody. Top panel shows the autoradiography. The same membrane was
probed with anti-phospho MEF2 antibody (middle panel) and then reprobed with an anti-MEF2D antibody for loading control (bottom panel).
(E) dnCdk5 blocks GAL4-MEF2D phosphorylation at Ser444 induced by hydrogen peroxide. Lysates from cortical neurons transfected with
indicated constructs and treated with H2O2 were first immunoprecipitated with an anti-GAL4 antibody and then analyzed with the phospho-
MEF2 antibody in Western blot assay (top panel). The levels of GAL4-MEF2D or GAL4-MEF2DS444A (same membrane) were about the same
as determined by anti-GAL4 Western blotting (bottom panel).
(F) H2O2 treatment induces a dosage-dependent phosphorylation of MEF2D in vivo. Primary cortical neurons were treated with H2O2 for 3 hr.
Western blot analysis using phospho-MEF2 antibody showed increased phosphorylation at Ser444 (top panel). Bottom panel shows the loading
control of MEF2D determined with an anti-MEF2D antibody.
was determined using the phospho-MEF2 antibody fol- phorylation on GAL4-MEF2D to the level of GAL4-MEF2-
DS444A (densitometry analysis adjusted for loading:lowing anti-GAL4 immunoprecipitation. Without hydro-
gen peroxide treatment, GAL4-MEF2D was phosphory- H2O2, 3.6-fold increase versus control; dnCDk5 and
GAL4-MEF2DS444A, 80% and 90% reduction versuslated at very low level at Ser444 compared to that of
vector/GFP control. Hydrogen peroxide increased the H2O2, respectively) (Figure 4E), suggesting that Cdk5 is
the major kinase in vivo directly involved in phosphoryla-level of phosphorylation at Ser444, and overexpression
of dnCdk5 reduced hydrogen peroxide-induced phos- tion of Ser444 following neurotoxic insults.
Inhibition of MEF2 by Cdk5
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Figure 5. Oxidative Stress Inhibits MEF2
Transactivation Activity in a Cdk5-Dependent
Manner
(A) H2O2 treatment inhibits MEF2 luciferase
reporter gene expression. Primary cortical
neurons were transfected with MEF2 lucifer-
ase reporter for 12 hr and then treated with
H2O2 for 10 hr. Roscovitine (10 M) or vehicle
(DMSO) was added to cells 8 hr following H2O2
treatment. Relative fold of luciferase activity
is presented with mutated MEF2 reporter set
as 1 following adjustment for -gal activity
(mean  SEM, n  3).
(B) Mutation at the Cdk5 phosphorylation site
Ser408 abolishes the inhibitory effect of H2O2
on GAL4-MEF2A-dependent reporter gene
expression (mean  SEM, n  3).
(C) dnCdk5 blocks the inhibitory effect of hy-
drogen peroxide on MEF2 function. Cortical
neurons transfected as indicated were
treated with hydrogen peroxide as described
in (A). Relative percentage of reporter activity
is shown with untreated wild-type reporter
activity set as 100% (mean  SEM, n  3).
Using this phospho-specific antibody, we further not due to an overall suppression of transcription, since
NTE reporter gene expression in the same assays wascharacterized hydrogen peroxide-induced phosphory-
lation of MEF2 in primary cortical neurons. Hydrogen not reduced (data not shown). More importantly, hydro-
gen peroxide-mediated inhibition of MEF2 was sensitiveperoxide treatment caused a dose-dependent increase
in the level of MEF2D phosphorylation at Ser444 without to Roscovitine and required the presence of Ser408 since
GAL4-MEF2AS408A largely escaped this inhibitory ef-significantly affecting the level of MEF2D protein (Figure
4F). Under these experimental conditions, no cellular fect (Figures 5A and 5B). Collectively, these studies indi-
cate that neurotoxin inhibits the activity of MEF2 in neu-morphological changes could be detected, suggesting
that change of MEF2 phosphorylation at Ser444 is an rons by phosphorylating MEF2 at its Cdk5-recognition
site Ser408a/444d.early event that may precede overt changes in neuronal
function following toxic insults. Since hydrogen peroxide-induced phosphorylation of
MEF2 at Ser408/444 is Cdk5 dependent (Figure 4E), we
tested if dominant-negative Cdk5 could restore MEF2Cdk5-Dependent Inhibition of MEF2
Transactivation Activity by Oxidative Stress activity following neurotoxic insults. MEF2 transactiva-
tion assays were carried as described in Figure 5A. Com-To investigate if neurotoxic insults inhibit MEF2 activity
via Cdk5, we performed MEF2 reporter assays in neu- pared to vector control (black bar), coexpression of
dnCdk5 (gray bar) rescued MEF2 function from the inhib-rons following oxidative stress. After transfection, corti-
cal neurons were treated with hydrogen peroxide, and itory effect of hydrogen peroxide in reporter assays (Fig-
ure 5C). Together, these results demonstrate that hydro-this resulted in a dose-related gradual decrease of MEF2
transactivation activity as determined by MEF2 reporter gen peroxide-induced inhibition of MEF2 function is
Cdk5 dependent.gene assays (Figure 5A). The observed inhibition was
Neuron
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Excitotoxicity-Induced Cdk5-Dependent of neurons (Mao et al., 1999; Okamoto et al., 2000).
We tested whether MEF2 mutants that are resistant toPhosphorylation and Inhibition of MEF2
Given that excitotoxicity is considered one of the major phosphorylation by Cdk5 may block or attenuate Cdk5/
p25-induced neuronal apoptosis by survival assays.pathological triggers of neurodegeneration, we asked if
the excitotoxin glutamate inhibits MEF2. Treating corti- Cortical neurons were transfected with constructs en-
coding green fluorescence protein (GFP) and Cdk5/p25.cal neurons with glutamate significantly reduced MEF2
reporter activity, and this inhibition could be reversed Following transfection, cells were stained with the nu-
clear dye propidium iodide without permeation and theby Roscovitine, suggesting that glutamate may inhibit
MEF2 through Cdk5 (Figure 6A). We tested if glutamate GFP-positive neurons were examined for nuclear mor-
phology (Blair et al., 1999). Overexpression of Cdk5/p25toxicity induces Cdk5 kinase activity. While glutamate
treatment did not alter the levels of Cdk5, a result consis- caused neuronal apoptosis (Figure 7A, middle row of
top panel). Cotransfection with a constitutively activetent with our nucleus immunocytochemical analysis (see
Supplemental Figure S1 at http://www.neuron.org/cgi/ form of MEF2 (MEF2CVP16, a fusion of N-terminal MEF2
DNA binding and dimerization domains to the strongcontent/full/38/1/33/DC1), it significantly increased cy-
toplasmic and nuclear Cdk5 kinase activity (110% and transactivation domain of the viral protein VP16 that
lacks the Cdk5 phosphorylation site) (Han et al., 1997;220%, respectively) (Figure 6B). In contrast to the tran-
sient increase in Cdk5 activity (less than 5 min) following Molkentin et al., 1996) reduced the level of Cdk5/
p25-induced neuronal apoptosis by over 90% (Figureactivation of metabotropic glutamate receptors (Liu et
al., 2001), Cdk5 activation after exposure to excitotoxic 7A, bottom panel). Cotransfection with mutant MEF2-
DS444A (expressed at a level comparable to that ofglutamate observed here is long lasting (more than 3
hr). Roscovitine largely reduced such an increase. Con- wild-type MEF2D) inhibited apoptosis by about 70%,
whereas overexpression of wild-type MEF2D was muchsistent with the increase in Cdk5 kinase activity, gluta-
mate also induced phosphorylation of endogenous less effective at reducing apoptosis, consistent with the
notion that Ser444 is a critical regulatory site by whichMEF2D at Ser444 in cortical neurons, which was reduced
by Roscovitine (Figure 6C). Together, these data sug- Cdk5 inhibits the survival-promoting function of MEF2.
The expression level of Cdk5 in transfected cells re-gest that Cdk5 may mediate glutamate-induced phos-
phorylation of MEF2. We tested if glutamate-induced mained about the same with or without coexpression
of MEF2s, suggesting that the observed reduction ofMEF2 phosphorylation is Cdk5 dependent in neurons.
We overexpressed GAL4-MEF2D in neurons as de- apoptosis was not due to changes in the level of Cdk5
expression (data not shown). These results clearly indi-scribed in Figure 4E, treated cells with glutamate as
described in Figure 6A, and measured phosphorylation cate that enhanced activity of MEF2 is sufficient to block
Cdk5/p25-induced neuronal apoptosis. Furthermore,at Ser444 by phospho Western blotting following anti-
GAL4 immunoprecipitation. Glutamate treatment in- they suggest that MEF2 functions downstream and is
one of the principal nuclear targets of Cdk5 in Cdk5-duced GAL4-MEF2D phosphorylation at Ser444 (Figure
6D, top panel). Coexpression of dnCdk5 reduced phos- mediated apoptosis.
Given that Cdk5 mediates the inhibitory effects ofphorylation at Ser444 to background level, suggesting
that Cdk5 is the major kinase in neurons that mediates oxidative stress on MEF2 (Figure 5), we asked whether
enhanced MEF2 function could block neurotoxin-inducedglutamate-induced phosphorylation of MEF2. In support
of this, dnCdk5 blocked glutamate-induced inhibition of apoptosis. Hydrogen peroxide treatment induced neu-
ronal apoptosis (Figure 7B, top panel). OverexpressionMEF2 reporter in cortical neurons, whereas dnCdk1,
which has been implicated in neuronal apoptosis of dif- of MEF2CVP16 or MEF2DS444A significantly reduced
the number of apoptotic neurons exposed to hydrogenferent experimental paradigms (Athanasiou et al., 1998;
Konishi et al., 2002; Zhang and Johnson, 2000) and peroxide while wild-type MEF2D had a partial but statis-
tically nonsignificant effect (Figure 7B, bottom panel).whose activity can be inhibited by Roscovitine, had no
significant effect (Figure 6E). Caspase inhibitors block Similarly, MEF2CVP16 and MEF2DS444A effectively re-
duced glutamate-induced neuronal apoptosis. More im-NMDA-induced neuronal apoptosis (Okamoto et al.,
2002). We tested the effect of a pan caspase inhibitor portantly, glutamate-induced neuronal apoptosis was
also blocked by dnCdk5 (Figure 7C). Together with theZ-VAD-fmk on glutamate/Cdk5-induced inhibition of
MEF2. Z-VAD-fmk blocked the inhibition of MEF2 re- findings presented in Figures 4–6, these results suggest
that Cdk5-dependent inhibition of MEF2-mediated nu-porter after exposure to glutamate, suggesting that inhi-
bition of caspase rescues glutamate-induced Cdk5- clear survival pathway is an important mechanism by
which neurotoxic insults induce neuronal death.dependent inhibition of MEF2. Consistent with this,
Z-VAD-fmk also reduced glutamate-induced Cdk5-
dependent phosphorylation of MEF2 (see Supplemental Discussion
Figures 5A and 5B). Taken together, our data suggest
that Cdk5 mediates the excitotoxic effect of glutamate Our findings demonstrate that the prosurvival nuclear
by targeting MEF2. factor MEF2 is a direct target of Cdk5 in neurotoxin-
induced apoptosis of primary cortical neurons. Phos-
phorylation of MEF2 by Cdk5 at a discrete site at its C’Prevention of Neurotoxin/Cdk5-Induced Neuronal
Apoptosis by Increasing MEF2 Activity transactivation domain, Ser408a/444d, inhibits MEF2 func-
tion. Neurotoxin enhances Cdk5 kinase activity in theDeregulation of Cdk5 activity induces neuronal apopto-
sis (Nguyen et al., 2001; Patrick et al., 1999). In contrast, nucleus. Through the Cdk5-MEF2 pathway, neurotoxin
inhibits the survival promoting function of MEF2 andMEF2 proteins promote the survival of different types
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Figure 6. Excitotoxin Glutamate Induces Cdk5-Dependent Phosphorylation and Inhibition of MEF2 in Neurons
(A) Glutamate inhibits MEF2 transactivation activity in cortical neurons. Primary cortical neurons were transfected as described in Figure 5A.
Sixteen hours after transfection, neurons were exposed to 50 M glutamate for 20 min in Earle’s balanced salt solution, rinsed, and replaced
in original conditional medium. Roscovitine (10 M) was added to cells 2 hr prior treatment. Luciferase reporter gene assays were performed
3 hr after glutamate exposure.
(B) Glutamate enhances nuclear and cytoplasmic Cdk5 kinase activity. Cortical neurons were treated with 50 M glutamate as described
above. Three hours after the exposure, in vitro Cdk5 kinase assay was performed following immunoprecipitation of Cdk5 from cytoplasmic
or nuclear extracts from control, glutamate, or glutamate/Roscovitine (10 M) -treated cortical neurons (prepared using Sigma EZ nuclei
isolation kit). The level of Cdk5 kinase activity was determined as described in Figure 2B. Levels of Cdk5 and p35/25 proteins were determined
by Western blot. Bottom panel indicates average of adjusted Cdk5 kinase activity (mean  SD, n  3).
(C) Glutamate induces phosphorylation of MEF2D at Ser444 in cortical neurons. Glutamate treatment induces phosphorylation of MEF2D in
vivo. Primary cortical neurons were treated as described in (B). Western blot analysis using phospho-MEF2 antibody shows increased
phosphorylation at Ser444 (top panel). Bottom panel shows the loading control of MEF2D determined with an anti-MEF2D antibody.
(D) dnCdk5 blocks glutamate-induced phosphorylation of MEF2D at Ser444. Cortical neurons were transfected as indicated. Sixteen hours after
transfection, neurons were treated with 50 M glutamate as described in (A). Three hours after the exposure, lysates were analyzed as
described in Figure 4E.
(E) dnCdk5 but not dnCdk1 reverses glutamate-induced inhibition of MEF2 transactivation activity. Cortical neurons were transfected as
indicated and treated with glutamate as described in (A). MEF2 luciferase reporter assays were performed 3 hr after glutamate exposure
(mean  SEM, n  3).
mediates neuronal apoptosis. The established function exclusively in the cytoplasmic compartment. A number
of cytoplasmic proteins have been identified as Cdk5for Cdk5 in regulation of neuronal development and apo-
ptosis has traditionally been ascribed to its role almost substrate. By phosphorylating these diverse cyto-
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Figure 7. Enhanced MEF2 Activity Inhibits Cdk5/p25- and Neurotoxin-Induced Apoptosis in Cortical Neurons
(A) MEF2 enhances the survival of cortical neurons overexpressing Cdk5/p25. Survival assays were carried out as described in Experimental
Procedures. Top panel shows immunocytochemical image of transfected neurons. Cotransfection of Cdk5/p25 induces apoptosis shown as
colocalization of propidium iodide (PI, shown in red) and GFP (shown in green) indicated by arrows (middle row of right panel: GFP/PI indicates
color merge; arrows in GFP/PI indicate GFP and PI colocalization). Cotransfection of MEF2C-VP16 rescues neurons from Cdk5/p25-induced
apoptosis (bottom row). Bottom panel is quantification of neuronal apoptosis. Data are the mean  SEM (n  3). Asterisk indicates p  0.01
versus Cdk5/p25 control.
(B) MEF2 enhances the survival of cortical neurons treated with hydrogen peroxide. Cortical neurons were transfected and treated with
hydrogen peroxide as described in Experimental Procedures. Top panel is propidium iodide staining of hydrogen peroxide-treated neurons.
GFP identifies transfected cells. Arrows indicate the colocalization of GFP and PI under GFP/PI. Cotransfection of MEF2C-VP16 rescues
transfected cells from H2O2-induced apoptosis. Bottom panel is quantification of neuronal apoptosis. Data are the mean  SEM (n  5).
Asterisk indicates p  0.01 versus H2O2 control.
(C) MEF2 and dnCdk5 enhance the survival of cortical neurons treated with glutamate. Cortical neurons were transfected as described in (B)
after 10 days in culture, treated with 50 M glutamate as described in Figure 6A, scored for death 12 hr later following PI staining. Data are
the mean  SEM (n  5).
(D) Model of Cdk5-mediated apoptosis through both cytoplasmic and nuclear pathways.
plasmic targets, Cdk5 plays a multifunctional role in 2001; Grant et al., 2001). Cdk5 mediates the hyperphos-
phorylation of the major cytoplasmic component of fi-neurons including neurite outgrowth, cytoskeleton as-
sembly, and synaptic transmission (Dhavan and Tsai, brillary tangle, tau, triggered by A, suggesting that
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Cdk5 may be involved in neuronal apoptosis via a cyto- pects of cell cycle machinery are reactivated during
neurodegeneration (Liu and Greene, 2001; Zhu et al.,plasmic mechanism (Alvarez et al., 1999; Maccioni et
al., 2001). On the other hand, MEF2 is a well-established 1999). Therefore, it is possible that dependent on the
pattern of reexpression and functional involvement,nuclear protein. Demonstrating the prosurvival tran-
scription factor MEF2 as a Cdk5 nuclear substrate re- other Cdks may phosphorylate MEF2 during neuronal
apoptosis under different conditions or target MEF2 withveals a novel molecular mechanism by which deregu-
lated Cdk5 couples neurotoxic insults to the nuclear different kinetics. Phosphorylation of MEF2 by Cdks
may represent a more general mechanism for cells tosurvival machinery, thus expanding the spectrum of pro-
cesses and substrates regulated by Cdk5 and establish- regulate MEF2 activity. On this note, it is tempting to
speculate that the often-observed poor transactivationing its role in the nucleus. These data suggest that in
response to toxic insults, Cdk5 may mediate neuronal activity of the endogenous MEF2 in actively proliferating
cells may be due to phosphorylation of MEF2 by highapoptosis through two distinct mechanisms, a cyto-
plasmic mechanism that triggers cytoskeleton disorga- levels of Cdks as cells progress through cell cycle. Con-
firming this would strengthen the importance of Cdk-nization and a nuclear mechanism that directly interferes
with the function of survival-related gene transcription dependent regulation of MEF2 and broaden its role, both
physiologically and pathologically, in proliferating and(model, Figure 7D).
Neuronal apoptosis induced by neurotoxin/Cdk5 re- postmitotic cells.
Increasing evidence suggests that MEF2 activity isquires downregulation of the transcriptional activity of
MEF2. Although the targets of MEF2 in neurons are not tightly regulated and correlated well with the process
of neuronal survival/apoptosis. Structurally, MEF2 tran-known at present (a subject for further studies), these
findings suggest that MEF2-mediated gene expression scription activity can be regulated through either its
N-terminal DNA binding/dimerization domain or itsplays an active role in promoting neuronal survival. Con-
sistent with this hypothesis, transcription-dependent C-terminal transactivation domain. Biochemically, two
modes of modification have been shown to regulatesurvival has been increasingly recognized as an impor-
tant mechanism that regulates survival and death of the C-terminal function of MEF2: phosphorylation and
protease-mediated cleavage. Contrary to Cdk5-inducedneurons (Brunet et al., 2001). In addition to MEF2, a
growing list of transcription factors has been shown to inhibition, phosphorylation of MEF2 by p38 MAPK or
ERK5 within the C-terminal domain at sites distinct frompromote neuronal survival in experimental paradigms.
Chief among them are nuclear factor-	B (NF-	B), cyclic serine 444 (or its equivalent among different isoforms
of MEF2) activates MEF2 (Han et al., 1997; Kato et al.,AMP response element binding protein (CREB), and Ret-
inoblastoma protein (Rb) (Bonni et al., 1999; Liu and 1997). This activation is required for neuronal activity-
or peptide growth factor-induced neuronal survival (MaoGreene, 2001; Mattson et al., 2000; Riccio et al., 1999;
Yoshikawa, 2000). It is likely that increased nuclear Cdk5 et al., 1999; Okamoto et al., 2000). Cdk5 represents the
first inhibitory MEF2 kinase identified. Phosphorylation-kinase activity in response to neurotoxic insults may
lead to the inhibition of other prosurvival nuclear factors induced inhibition of MEF2 function is consistent with
the observation that neuronal apoptosis correlates within addition to MEF2. In support of this notion, Cdk5 has
been shown to phosphorylate Rb in vitro (Lee et al., hyperphosphorylation of MEF2A and D (Li et al., 2001;
Mao and Wiedmann, 1999). How phosphorylation by1997). Recently, it was reported that Cdk5 could phos-
phorylate p53 in vitro (Zhang et al., 2002). p53 promotes Cdk5 at Ser444 inhibits MEF2 function is a subject requir-
ing further investigation. One possibility is that phos-apoptosis of many cell types including neurons (Mattson
et al., 2001; Miller et al., 2000). Together with our data, phorylation at Ser444 may target MEF2 to specific prote-
ase cleavage/degradation pathways. In support of this,these findings point to an active role of Cdk5 in the
regulation of neuronal apoptosis. Interestingly, Cdk5 has caspases have been shown to cleave MEF2 proteins in
neurons (Li et al., 2001; Okamoto et al., 2002). Consistentbeen implicated in apoptosis of nonneuronal cells during
development and in adult tissues. This raises the possi- with this hypothesis, our data show that Z-VAD blocks
glutamate-induced inhibition of MEF2 transactivationbility that Cdk5-targeted inhibition of nuclear survival
machinery may represent a general strategy by which activity. Interestingly, Z-VAD also reduces the phos-
phorylation of MEF2 at Ser444 after exposure to gluta-Cdk5 promotes apoptosis in both neuronal and nonneu-
ronal tissues under either physiological or pathological mate. Since caspases are not known to regulate Cdk5/
p35 directly and our data show that Z-VAD-fmk failedconditions (Ahuja et al., 1997; Gao et al., 2001; Zhang
et al., 1997). to reverse the inhibition of MEF2 by direct overexpres-
sion of Cdk5 (see Supplemental Figure 5C at http://Combining the approaches of pharmacological inhibi-
tor and dominant-negative mutant, our biochemical and www.neuron.org/cgi/content/full/38/1/33/DC1), these re-
sults suggest that inhibiting caspases may enhancebiological data identify Cdk5 as the major kinase that
mediates neuronal death induced by oxidative stress MEF2 function through both direct and indirect mecha-
nisms. Other possibilities include that Ser444 phosphory-and glutamate in cortical neurons in our experimental
paradigm. It does so in part through phosphorylation lation changes the confirmation of MEF2 that alters its
interaction with coregulators or basal transcription ma-and inhibition of the neuro-protective function of MEF2.
Although Cdk5 is not regulated by cell cycle and plays chinery. Or alternatively, phosphorylation at Ser444 may
render MEF2 inactive by preventing it from being acti-a unique role in postmitotic neurons, it shares with other
classic Cdks, such as Cdk1 or 4/6, the phosphorylation vated by p38MAPK or sequestering it from active site.
Abnormal regulation of Cdk5 has been associatedconsensus site. This raises the possibility that other
traditional Cdks may also target MEF2 in a different with a growing list of neurodegenerative disorders in-
cluding AD, ALS, Parkinson’s disease, and Niemann-cellular context. Recent studies suggest that certain as-
Neuron
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the labeled protein bands were excised for elution. Eluted proteinsPick Type C (Bajaj et al., 1998; Brion and Couck, 1995;
were digested with trypsin, and the resulting tryptic peptides wereBu et al., 2002; Nguyen et al., 2001; Patrick et al., 1999;
analyzed by two-dimensional electrophoresis. In some cases, phos-Sisodiya et al., 2002). One important common feature
phopeptides were recovered from thin-layer chromatography plates
of these diseases is pathological apoptosis triggered by and then analyzed for phosphoamino acid content.
neurotoxic insults. In light of the finding that neurotoxic-
ity inhibits MEF2 function as a consequence of Cdk5- Reporter Gene Assays
Primary cortical neurons were transiently transfected with variousdependent phosphorylation, our studies presented here
constructs using calcium phosphate transfection procedure as de-may have broad implications in the pathogenesis of neu-
scribed (Mao et al., 1999). A -galactosidase expression plasmidrodegeneration. They suggest that the decreased func-
was used to determine the transfection efficiency in each transfec-
tion of survival-promoting transcription factors such as tion. The total amount of DNA for each transfection was kept con-
MEF2 may precede and contribute to the critical stages stant by using a control vector. At various time points following
of neuronal loss found in many neurodegenerative dis- transfection (indicated in figure legend), cell lysates were analyzed
for luciferase according to the manuscript’s instruction (BD Biosci-eases (Mattson, 2000; Yuan and Yankner, 2000). Demon-
ence) and -gal activity.strating that an increase in MEF2 activity can reduce
neurotoxicity/Cdk5-mediated neuronal loss provides a
Survival Assaysnew potential therapeutic target for the prevention and
Primary neurons were transfected with a vector for GFP in combina-
treatment of these devastating illnesses. tion with other constructs as indicated in the figure legend. The total
amount of DNA for each transfection was kept constant by using
Experimental Procedures control vector for -gal. Twenty-one hours after transfection, neu-
rons were stained with propidium iodide as described (Blair et al.,
Chemicals and Antibodies 1999). GFP-positive cells with or without apoptotic nuclei (pyknotic
Polyclonal rabbit antibody was raised against a phosphoserine- or fragmented) were counted using a fluorescence microscope in
containing peptide corresponding to a sequence containing SPXR a blinded manner. Three hundred or more transfected cells were
motif found in MEF2s. Anti-GAL4, anti-Histone H1, and anti-Cdk5/ counted for each treatment. Apoptotic rates were represented as
p35 antibodies were purchased from Santa Cruz Biotechnology, the percentage of apoptotic cells out of the total number of GFP-
anti-c-Raf-1 antibody from BD Bioscience, and anti-MEF2D anti- positive cells counted. For H2O2 assay, neurons were treated with
body from Signal Transduction Laboratory. Propidium iodide and H2O2 14 hr after transfection for 24 hr, and then stained and counted
glutamate were purchased from Sigma. Roscovitine was purchased as described above.
from Calbiochem. H2O2 was purchased from Fisher Scientific.
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